CHCT(CHCT)
CHCT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $128M | $134M | $139M | $142M | $145M |
| Low | $126M | $133M | $137M | $140M | $143M |
| High | $130M | $137M | $142M | $144M | $147M |
| EBITDA Avg | $82M | $87M | $90M | $92M | $93M |
| Low | $81M | $85M | $89M | $90M | $92M |
| High | $84M | $88M | $91M | $93M | $95M |
| EBIT Avg | $37M | $39M | $40M | $41M | $42M |
| Low | $36M | $38M | $40M | $40M | $41M |
| High | $37M | $39M | $41M | $42M | $42M |
| Net Income Avg | $13M | $16M | — | — | — |
| Low | $12M | $16M | — | — | — |
| High | $13M | $16M | — | — | — |
| EPS Avg | $0.47 | $0.59 | — | — | — |
| Low | $0.46 | $0.58 | — | — | — |
| High | $0.48 | $0.60 | — | — | — |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / — | 1 / — | 1 / — |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $32M | $32M | $32M | $34M | $34M | $35M | $35M |
| Low | $31M | $32M | $32M | $33M | $34M | $34M | $35M |
| High | $32M | $32M | $33M | $34M | $34M | $35M | $35M |
| EBITDA Avg | $20M | $21M | $21M | $22M | $22M | $22M | $23M |
| Low | $20M | $21M | $21M | $21M | $22M | $22M | $22M |
| High | $21M | $21M | $21M | $22M | $22M | $22M | $23M |
| EBIT Avg | $9M | $9M | $9M | $10M | $10M | $10M | $10M |
| Low | $9M | $9M | $9M | $10M | $10M | $10M | $10M |
| High | $9M | $9M | $9M | $10M | $10M | $10M | $10M |
| Net Income Avg | $3M | $3M | $4M | $4M | $4M | $4M | $4M |
| Low | $3M | $3M | $3M | $4M | $4M | $4M | $4M |
| High | $3M | $3M | $4M | $4M | $4M | $4M | $4M |
| EPS Avg | $0.12 | $0.12 | $0.13 | $0.14 | $0.15 | $0.15 | $0.16 |
| Low | $0.12 | $0.12 | $0.13 | $0.14 | $0.15 | $0.15 | $0.16 |
| High | $0.12 | $0.12 | $0.13 | $0.14 | $0.15 | $0.15 | $0.16 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |